Vascular adhesion of circulating tumor cells (CTCs) is a key step in cancer spreading. If inflammation is recognized to favor the formation of vascular 'metastatic niches', little is known about the contribution of blood rheology to CTC deposition. Herein, a microfluidic chip, covered by a confluent monolayer of endothelial cells, is used for analyzing the adhesion and rolling of colorectal (HCT-15) and breast (MDA MB-231) cancer cells under different biophysical conditions. These include the analysis of cell transport in a physiological solution and whole blood; over a healthy and a TNF-a inflamed endothelium; with a flow rate of 50 and 100 nL/min. Upon stimulation of the endothelial monolayer with TNF-a (25 ng/mL), CTC adhesion increases by 2 to 4 times whilst cell rolling velocity only slightly reduces. Notably, whole blood also enhances cancer cell deposition by 2 to 3 times, but only on the unstimulated vasculature. For all tested conditions, no statistically significant difference is observed between the two cancer cell types.
INTRODUCTION
The formation of distant metastasis from a primary neoplastic mass is a very inefficient biological process. (Talmadge and Fidler 2010; Nguyen, Bos, and Massague 2009; Wirtz, Konstantopoulos, and Searson 2011; Joyce and Pollard 2009 ) Spreading of cancer cells evolves following a precise cascade of events -the metastatic cascade -requiring cell migration away from the primary mass and intravasation into blood or lymphatic vessels, following the epithelial to mesenchymal transition; circulation within the blood stream, where cells have to survive hemodynamic stresses and immune cell recognition; extravasation, migration and proliferation at the secondary sites. Radioactive assays documented that only 1% of circulating tumor cells (CTCs) can successfully overcome all these sequential steps and eventually establish distant metastases. (Fidler 1970) Despite the inefficiency and complexity of the process, the vast majority of cancer patients who relapse eventually succumb because of metastases, disseminated at different secondary sites, rather than for the uncontrolled growth of the original malignancy. (Chaffer and Weinberg 2011) CTC arrest within different vascular districts is a key step in the metastatic cascade and is primarily mediated by two mechanisms: vascular occlusion, which generally occurs in the small capillary beds of the brain and lungs (Kienast et al. 2010) ; and vascular adhesion, which is regulated by specific interactions between receptor molecules on the endothelium and ligand molecules on CTCs. (Schluter et al. 2006; Witz 2008 ) A wide range of vascular molecules are involved in this specific adhesion process, including E-and P-selectins, avb3 and avb5 integrins, VCAM-1 and ICAM-1 adhesion molecules. (Burdick et al. 2003; Barthel et al. 2007; Myung et al. 2011 ) These receptors can bind several different ligands expressed on the CTC membrane, making target therapies against metastasis practically impossible. This picture is further complicated by the fact that platelets, leukocytes and CTCs tend to form in the circulation stable aggregates that favor blood longevity and vascular deposition of malignant 4 cells. (Gay and Felding-Habermann 2011; Borsig et al. 2002) In this context, pro-inflammatory cytokines (Solinas et al. 2010; Kim et al. 2009 ), such as TNF-a, IL-1b and IL-6; tumor-derived exosomes (Hoshino et al. 2015; Hood, San, and Wickline 2011) and hematopoietic cells (Kaplan et al. 2005; Shiozawa et al. 2011 ) have been shown to modulate the expression of adhesion molecules in specific vascular districts thus priming the formation of so called 'pre-metastatic niches' where CTCs more efficiently, and in a larger number, accumulate.
Cell-cell adhesion is strongly modulated by external forces and, as such, static assays may not always reproduce the complex interactions developing under flow within the vasculature. Intravital microcopy has been extensively employed to document cell migration within vascular and extravascular compartments, (Kienast et al. 2010; Provenzano, Eliceiri, and Keely 2009 ) however these in vivo analyses lack a precise control on the governing parameters. On the other hand, microfluidic chips allow to precisely control blood vessel sizes, flow rates and the expression of vascular adhesion molecules and are amenable for high through-put systematic characterizations. A variety of microfluidic chips are being developed for studying the different steps in the metastatic cascade. For instance, the group of Kamm designed flow devices for assessing transvascular migration of cancer cells in different extravascular matrices. (Bersini et al. 2014; Jeon et al. 2015; Niu et al. 2014; Zervantonakis et al. 2012) The vascular adhesion and transmigration of individual and clustered CTCs was studied under chemokine stimulation (exposure to CXCL12 and SDF-1a) by various groups. (Song et al. 2009; Zhang, Liu, and Qin 2012; Roberts, Waziri, and Agrawal 2016) Studies of cancer cell migration within the lymphatic system were presented by Swartz and collaborators. (Pisano et al. 2015) The group of Jiang focused on investigating the role of endothelial cell mechanical (cyclic shear stresses) and biochemical (exposure to TNF-a) stimulation on CTC vascular adhesion. Huang and collaborators developed cellulose-5 based tubular artificial blood vessels for reproducing the intravasation, vascular adhesion and extravasation of cancer cells. (Wang et al. 2015) Although red blood cells (RBCs) are known to affect the dynamics of leukocytes and CTCs, at authors' knowledge, no studies have addressed the relative roles of vascular inflammation and RBC dynamics on the vascular deposition of malignant cells. In this work, a microfluidic chip is used to study the rolling and firm adhesion of breast (MDA-MB-231) and colorectal cancer (HCT-15) cells on a confluent layer of human vascular endothelial cells (HUVECs). The hematocrit of the working solution ranges from 0 to 40% and TNF-a is used for stimulating HUVECs. The rolling velocity and number of firmly adhering tumor cells are measured under different conditions. A Lattice-Boltzmann computational model is also included to interpret and reproduce the vascular adhesion dynamics of cells.
RESULTS AND DISCUSSIONS
A continuously growing body of evidence documents that vascular inflammation supports the firm adhesion of circulating tumor cells (CTCs) and facilitate the distant colonization of otherwise healthy tissues with the consequent formation of tumor metastases. (Solinas et al. 2010; Kim et al. 2009; Hoshino et al. 2015; Hood, San, and Wickline 2011) In this context, human vascular endothelial cells (HUVECs) were stimulated with the pro-inflammatory cytokine TNF-α and the adhesion propensity of cancer cells (HCT-15 and MDA-MB-231) was assessed under static and dynamic conditions. The two cell lines are among the most metastatic and aggressively growing colon and breast cancer cells, respectively. (Flatmark et al. 2004; Holliday and Speirs 2011) Cancer cell adhesion on inflamed endothelial cells under dynamic conditions. HUVECs were seeded in multiwell plates and, after reaching confluency, were stimulated with TNF-α (10 ng/mL, 25 ng/mL 50 6 ng/mL) for 6 hours. Cancer cells were added to the multiwell plates and left interacting with the endothelial cells up to 4 hours, under static conditions. In agreement with a large body of literature, these static experiments continue to confirm that endothelial stimulation with a pro-inflammatory cytokine (TNF-α) favors CTC vascular adhesion in a dose dependent manner (Supporting Figure.1 and 2) .
Moving from static to dynamic experimental conditions, a PDMS single-channel microfluidic chip was used for monitoring the interaction of cancer and endothelial cells under flow ( Figure. As expected, the rolling velocity slightly but steadily decreased as the level of TNF-α stimulation increased. At 100 nL/min, the rolling velocities for the HCT-15 cells were 163.6 ± 20.10 µm/sec (-TNF-α), 157.4 ± 4.531 µm/sec (TNF-α 6h) and 158.06 ± 1.187 µm/sec (TNF-α 12h). For the MDA-MB-231, the same physical quantity took the values 170.9 ± 11.03 µm/sec (-TNF-α); 151.8 ± 8.182 µm/sec (6h TNF-α) and 144.9 ± 1.500 µm/sec (12h TNF-α).
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Lastly, the ratio between the number of rolling and adhering cells was plotted for two different flow conditions ( Figure. Specifically, experimental observation and simulations have shown that the deformability and shape of RBCs allow them to concentrate within the core of blood vessels leaving a so-called 'cell free layer' next to the vessel walls. (Goldsmith, Cokelet, and Gaehtgens 1989; Pappu and Bagchi 2007; Fedosov, Noguchi, and Gompper 2014; Firrell and Lipowsky 1989) Leukocytes, which are two-times larger and far less abundant than RBCs, tend to be pushed laterally in the cell free layer by the fast moving RBCs.
This process, known as 'margination', should also affect the vascular behavior of CTCs.
In this section, cancer cell rolling and adhesion over a monolayer of HUVECs is analyzed in the presence of whole blood. The single-channel microfluidic chip was again covered by a confluent monolayer of HUVECs, which were unstimulated or stimulated with TNF-α (12h only), and cancer cells re-suspended in whole blood were directly injected at two different flow rates (Q = 50 and 100 nL/min). Whole blood, freshly drawn from rats, contained all the cell and molecular components of blood, including red blood cells, platelets, leucocytes and plasma proteins which may all contribute, at different extents, to cancer cell rolling and adhesion. (Gay and Felding-Habermann 2011; Borsig et al. 2002) A fixed hematocrit of 40% was considered. Results for eight different working conditions are provided in Figure. and f would lead one to infer that, at higher flow rates (100 nL/min), the density of firmly adhering CTCs on the inflamed and normal vasculature is comparable when a whole blood flow is considered. Again, this could be due to a balance between shear stresses and cell-cell collisions. Indeed, this is not observed at low flow rates (50 nL/min), where adhesion is higher on inflamed endothelium. At first, cancer cells were assumed to be rigid, which is indeed the simplest possible hypothesis. Then, simulations were performed for estimating the rolling velocities of cancer cells over the vascular wall as a function of four different flow rates, namely Q = 25, 50, 75, and 100 nL/min; and two " ratios, namely 0.3 and 0.6. The resulting data are shown in Figure. 5b (lines) where a direct comparison with the corresponding experimental data is also included (blue dots for HCT-15 cells). From the simulations, the cell rolling velocity was predicted to grow quasi-linearly with the flow rate Q (R 2 = 0.998 and 0.994 for " = 0.3 and 0.6, respectively) and slightly decrease with an increase in " = 0.3. Overall, the predicted rolling velocities were found to be in good agreement with the experimental data for Q = 100 nL/min, returning a relative error smaller than 0.74% and 3.10% for " = 0.3 and 0.6, respectively. A larger 13 difference was observed at low flow rates, Q = 50 nL/min, where the relative error increased to about 43.01% and 52.07% for " = 0.3 and 0.6, respectively. This might be due to the fact that this flow rate is very close to the lower limit for the syringe pump used in the experiments. Note that an increase in " from 0.3 to 0.6 was associated with only a 3.5% decrease in rolling velocity. This is also in agreement with the experimental data of Figure. 3a and b documenting a modest variation in uroll with vascular inflammation.
Although the 'rigid cell' approximation quite accurately modeled the rolling behavior of cancer cells, it could not predict their firm vascular adhesion. Therefore, in a second set of simulations, the cancer cell was considered as a deformable capsule characterized by the dimensionless capillary number Ca = 10 -2 .
These data are plotted in deformation and increase in the number of ligand-receptor bonds. However, after reaching a maximum, the adhesive interactions were not sufficient to counteract the dislodging hydrodynamic forces and, consequently, the number of close bonds reduced tending eventually to zero. For " =0.6, a larger number of ligand-receptor bonds could be formed leading to stronger adhesive interactions. This is indeed observed in the plots of Figure. 5c and f. Also, for sufficiently high flow rates (Q ³ 50 nL/min), partially adhering soft cells were deformed and pushed down to the wall thus maximizing their adhesive surface and interface forces and leading to a 2 to 3-times higher number of ligand-receptor bonds as compared to the corresponding rigid cell cases ( Figure.5e and f) . Notably, simulations predicted that rigid cells would roll over the endothelium with a rolling velocity decreasing with an increasing surface density of ligands (black and blue lines in Figure. It was confirmed that vascular inflammation facilitates cell adhesion in a way proportional to TNF-a stimulation, whereas high flow rates are associated with lower cell deposition. Rolling velocities are only slightly affected by vascular inflammation and grow proportionally with the flow rate. As compared to a physiological solution, flowing cancer cells in whole blood enhances their firm deposition on healthy endothelium rather than on the inflamed vasculature, for all tested conditions. No statistically significant difference is observed for adhesion and rolling between HCT-15 and MDA-MB-231 cells.
These results would imply that neglecting the contribution of whole blood in the analysis of cancer cell dynamics can significantly underestimate their vascular deposition. Furthermore, it can be concluded that 15 whole blood flow supports cancer cell deposition and facilitates metastatization over the entire microvasculature.
EXPERIMENTAL SECTION
Fabrication of a single channel microfluidic chip. The single channel microfluidic chip was fabricated following protocols previously demonstrated by the authors. (Manneschi et al. 2016 ) Briefly, a SU8-50 master was used as a mold for PDMS replicas of the chip. First a 40 µm thick layer of SU8-50 photoresist (MicroChem) was spin coated on a silicon wafer (4"-P doped -<100> -10 ÷ 20 W/cm 2 -525 µm thick, from Si-Mat) at 2000 rpm for 30 s. Then, the negative SU8-50 template was pre-and soft baked for solvent evaporation; exposed to UV light and baked again for epoxy crosslinking; and finally developed.
This template was replicated using a mixture of PDMS and curing agent Sylgard 182 (Dow Corning Corporation), with a ratio (w:w) 10:1. Specifically, the mixture was poured on the SU8-50 template, cured in an oven at 60°C for 15 h, and moved at -20°C for 1 h. After peeling off from the template, the channel extremities of the PDMS replica were punched via a biopsy puncher (OD = 1 mm, Miltex) to form inlet and outlet ports. Finally, upon oxygen plasma treatment (Pressure = 0.5 mBar, Power = 15 w, Time = 15 s; Plasma System Tucano, Gambetti), PDMS replica was sealed with a glass slide (20 x 60 x 0.17 mm) (No. 1.5H, Deckaläser). The resulting microfluidic chip has a rectangular cross section with a width w = 210 µm, height h = 42 µm, and a port-to port length l = 2.7 cm.
Seeding of endothelial cells into the microfluidic chip. Chips were sterilized by autoclave, dried and covered with 20 µg/mL of fibronectin to allow cell adhesion. HUVECs were introduced in the channel from the inlet port at a density of 3×10 6 cells/mL by using a pipette tip. Then, chips were placed in an incubator, to allow cell attachment and growth, and continuously perfused with Endothelial cell growth medium supplement-mix (PROMOCELL) until cell confluency was achieved. HUVEC monolayers were 16 inflamed, at the occurrence, with 25 ng/mL of TNF-α for 6 or 12 hours. Each experiment was compared to untreated HUVEC monolayer (-TNF-α).
Cancer cell adhesion and rolling under dynamic conditions. The microfluidic chip was placed on the stage of an epi-fluorescence inverted microscope (Leica 6000). The working fluid was injected into the chip using a syringe pump 33 Dual (Harvard apparatus). After the tripsinization, the cancer cells were Each experiment was repeated three times for each different conditions and flow rates. For the study of cell adhesion under whole blood flow, the working fluid was obtained by combining a cancer cell suspension (density of 10 6 cells/mL) with whole blood from rat, collected in a standard blood test tubing containing 3.2% of buffered citrate to prevent clotting. The working hematocrit was fixed to 40%.
Experiments and image acquisition were performed as described above.
SUPPLEMENTARY MATERIALS
See supplementary material for the complete description of the materials and methods used in the cell culturing; CTCs adhesion measurement in static and dynamic conditions; and computational modelling.
Supplementary material include also supporting figures and movies about CTCs adhesion and rolling on inflamed endothelium, the computed adhesion mechanics of deformable cells, and confocal microscopy images of the adhesion molecules in the microfluidic chip. This number is computed as the ratio between the current number of closed bonds over the number of closed bonds in the initial configuration."
